DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Targeted therapy
Targeted therapy
Side Effects of Targeted Therapy
Cancer Diagnosis Y Tumor Stage Second Emergency Visits…
Protein Kinase C As a Therapeutic Target in Non-Small Cell Lung Cancer
Changing the Destiny of HER2 Expressing Solid Tumors
Trastuzumab Deruxtecan for Metastatic HER2 - Positive Breast Cancer – Second Line
Opportunities and Challenges in the Development of Kinase Inhibitor Therapy for Cancer
Trastuzumab: a Picky Partner? □□ Commentary on Francia Et Al., P
Kinase-Targeted Cancer Therapies: Progress, Challenges and Future Directions Khushwant S
Effects of Removing Reimbursement Restrictions on Targeted Therapy Accessibility for Non-Small Cell Lung Cancer Treatment in Taiwan: an Interrupted Time Series Study
The Role of BRAF-Targeted Therapy for Advanced Melanoma in the Immunotherapy Era
Brentuximab Vedotin: First-Line Agent for Advanced Hodgkin Lymphoma
Knocking out Melanoma with Targeted Therapy
Targeted Therapy for Resistant Cholangiocarcinoma with Bevacizumab Or Cetuximab Added to Failed Cytotoxic Drug Cores
Effectiveness of EGFR/HER2-Targeted Drugs Is Influenced by The
Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy
Kinase Drug Discovery 20 Years After Imatinib: Progress and Future Directions
(Trastuzumab-DM1) for Treatment of HER-2 Positive Malignancies
Information for Patient Taking Oral Targeted Therapy Imatinib
Top View
Effective Combinatorial Immunotherapy for Penile Squamous Cell Carcinoma
The Legally Binding Text Is the Original French Version TRANSPARENCY COMMITTEE OPINION 2 February 2011 VOTRIENT 200 Mg, Film-Coa
Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer Funda Meric-Bernstam1,2,3, Amber M
Novel HER2-Directed Treatments in Advanced Gastric Carcinoma: Another Paradigm Shift?
Venetoclax-Based Therapies for Acute Myeloid Leukemia T ∗ Veronica A
Current State of Target Treatment in BRAF Mutated Melanoma
As an Inhibitor of KSHV Driven Primary Effusion Lymphoma Via Disruption of Mitochondrial OXPHOS Metabolism
Ado-Trastuzumab Emtansine for the Adjuvant Treatment of HER2
Combinatory Therapy Targeting Mitochondrial Oxidative
Excellent Outcomes Reported for First Targeted Therapy for Pediatric Hodgkin Lymphoma 8 April 2021
Press Release
Longitudinal Trends in Use and Costs of Targeted Therapies for Common Cancers in Taiwan: a Retrospective Observational Study
Clinical Use of Tyrosine Kinase Inhibitors: Therapy for Chronic Myelogenous Leukemia and Other Cancers
DRUG NAME: Bevacizumab
My Journey from Tyrosine Phosphorylation Inhibitors to Targeted Immune Therapy As Strategies to INAUGURAL ARTICLE Combat Cancer
Capture of Systemic Anticancer Therapy Use by Routinely Collected Health Datasets
Statistical Analysis Plan
Targeted Therapy and the T315I Mutation in Philadelphia-Positive Leukemias